GlassScriptPhysician profile
Austin Ellis
NPI 1760370340
$1,762.22
in general payments reported to CMS, 2019-2025
9 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $469.46 | 2025 | Allofiber |
| Integra Lifesciences Corporation | $359.55 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Blue Surgical LLC | $251.94 | 2025 | |
| Lifenet Health | $250.94 | 2025 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $124.93 | 2025 | |
| Bioventus LLC | $105.32 | 2025 | Exogen Ultrasound Bone Healing System |
| Avita Medical Americas, LLC | $101.49 | 2025 | Permeaderm, Cohealyx, Recell |
| Convatec INC. | $87.95 | 2025 | |
| Trice Medical, INC. | $10.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.